Current Pharmaceutical Design

Volume 7, Number 13, 1 September 2001

Links for this Journal

Book Reviews

Preface
pp. i-ii(1)
Authors: Hill, B.T.; Fahy, J.

Links for this article

Reviews

Modifications in the upper or Velbenamine Part of the Vinca Alkaloids have Major Implications for Tubulin Interacting Activities
pp. 1181-1197(17)
Author: Fahy, J.

Links for this article

Vinflunine, a Second Generation Novel Vinca Alkaloid with a Distinctive Pharmacological Profile, now in Clinical Development and Prospects for Future Mitotic Blockers
pp. 1199-1212(14)
Author: Hill, B.T.

Links for this article

Physiochemical Aspects of Tubulin-Interacting Antimitotic Drugs
pp. 1213-1228(16)
Authors: Correia, J.J.; Lobert, S.

Links for this article

General and Recent Aspects of the Chemistry and Structure Activity Relationships of Taxoids
pp. 1229-1249(21)
Author: Gueritte, F.

Links for this article

Preclinical Evaluation of New Taxoids
pp. 1251-1257(7)
Author: Bissery, M.

Links for this article

Cryptophycins: A Novel Class of Potent Antimitotic Antitumor Depsipeptides
pp. 1259-1276(18)
Authors: Shih, C.; Teicher, B.A.

Links for this article

The Epothilones, Eleutherobins, and Related Types of Molecules
pp. 1277-1290(14)
Authors: Stachel, S.J.; Biswas, K.; Danishefsky, S.J.

Links for this article

Spongistatins as Tubulin Targeting Agents
pp. 1291-1296(6)
Authors: Uckun, F.M.; Mao, C.; jan, S.; Huang, H.; Vassilev, A.O.; Navara, C.S.; Narla, R.K.

Links for this article

Epilogue
pp. 1297-1301(5)
Authors: Fahy, J.; Hill, B.T.

Links for this article